The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells …PR Newswire India (press release)Therapeutic monoclonal antibodies have become an increasingly successful treatment modality with sales of US$ 65 bln in the year 2012 and with…
Perez Teams Up With Force India for 2014 Season – Heart
|
Perez Teams Up With Force India for 2014 Season
Heart The former McLaren driver has found refuge at the midfield outfit having been axed in favour Kevin Magnussen despite believing his seat alongside Jenson Button was secure for next season. “Coming here was always my first choice and I’m really happy … |
Doctors at UMMC complete state's first pancreas transplant – Mississippi Business Journal (blog)
|
Doctors at UMMC complete state’s first pancreas transplant
Mississippi Business Journal (blog) “Our goal has been to build a complete and high-functioning abdominal transplant program,” said Dr. Christopher Anderson, UMMC associate professor of transplant surgery and division chief of transplant and hepatobiliary surgery. “The pancreas … Hackensack University Medical Center kidney transplant program fully reactivatedNorthJersey.com |
BioVentrix Expands Life-Extending Transcatheter Heart Failure Treatment to … – PharmiWeb.com (press release)
|
BioVentrix Expands Life-Extending Transcatheter Heart Failure Treatment to …
PharmiWeb.com (press release) BioVentrix a pioneer of technologies and procedures for less-invasive treatment of heart failure (HF) today announced that placement of its Revivent-TC™ Ventricular Enhancement System via Less Invasive Ventricular Enhancement™ or the LIVE™ … |
Overcoming cultural qualms over organ donation – SBS
SBS |
Overcoming cultural qualms over organ donation
SBS Rabbi Freilich says one way to help medical professionals identify any conditions a certain group, such as the Jewish community, places on organ donation would be to include specific labelling on driving licences. He says it’s a recommendation he’s … The Gift of Life Can Start & Continue With YouInland Valley News Gift of Hope Honors Illinois Donor FamilyMarketwired (press release) Rose Parade to honor Duffy (with video)Braintree Forum |
BioVentrix Expands Life-Extending Transcatheter Heart Failure Treatment to … – Business Wire (press release)
|
BioVentrix Expands Life-Extending Transcatheter Heart Failure Treatment to …
Business Wire (press release) SAN RAMON, Calif. & PRAGUE–(BUSINESS WIRE)–BioVentrix, a pioneer of technologies and procedures for less-invasive treatment of heart failure (HF), today announced that placement of its Revivent-TC™ Ventricular Enhancement System, via Less … |
Research and Markets: Global Congestive Heart Failure Pipeline Highlights – 2014 – Business Wire (press release)
Research and Markets: Global Congestive Heart Failure Pipeline Highlights – 2014Business Wire (press release)The latest report Congestive Heart Failure Pipeline Highlights – 2014, provides most up-to-date information on key pipeline molecules in the gl…
Organ donation the best gift of all – Ballarat Courier
|
Organ donation the best gift of all
Ballarat Courier Organ donation the best gift of all. By FIONA HENDERSON. Dec. 12, 2013, 11:30 p.m.. TWO years ago, Ballarat’s Graham Mitchell was looking forward to a family Christmas get-together. Jo Forteath, nurse donation specialist with Donate for Life, with … |
Roche, Prothena to develop new antibodies for Parkinson's disease treatment – Pharmaceutical Business Review
Economic Times |
Roche, Prothena to develop new antibodies for Parkinson’s disease treatment
Pharmaceutical Business Review Roche and Prothena have agreed to jointly develop and commercialize new antibodies that target alpha-synuclein, including PRX002, Prothena’s monoclonal antibody for the treatment of Parkinson’s disease (PD). Currently, PRX002 is in preclinical … Roche and Prothena to Devlop Antibodies for Parkinson’s DiseasePharmaceutical Processing Roche and Prothena Enter Into Worldwide Collaboration to Co-Develop and Co …4-traders (press release) Roche, Prothena in $600M Parkinson’s…PharmaLive (press release) (subscription) Genetic Engineering News all 32 news articles » |
Emergent announces positive results from phase 1b study of otlertuzumab in … – pharmabiz.com
Emergent announces positive results from phase 1b study of otlertuzumab in …pharmabiz.comEmergent BioSolutions Inc., a specialty pharmaceutical company, has reported preliminary results from a phase Ib single-arm, open-label study evaluating the safe…